DxLab
DxLab Inc. is dedicated to setting a new standard for infectious disease testing by developing rapid, accurate, and affordable diagnostic solutions. Their flagship product, DxHub, is a standalone point-of-care molecular testing system capable of delivering PCR-quality results in as little as 10 minutes, even under high patient volume. The company aims to minimize the spread and impact of infectious diseases through innovative testing technology, combining patent-pending isothermal nucleic acid amplification chemistry with machine learning-based design optimizations. DxLab is committed to making a significant impact in diagnostic testing and invites interdisciplinary collaboration to develop new solutions.
Industries
Nr. of Employees
small (1-50)
Products
Standalone point-of-care molecular testing system
Compact, on-site molecular testing instrument that performs individual sample nucleic acid testing with rapid turnaround and multi-sample capability.
Standalone point-of-care molecular testing system
Compact, on-site molecular testing instrument that performs individual sample nucleic acid testing with rapid turnaround and multi-sample capability.
Services
Assay development and partnership collaborations
Collaborative development of infectious disease molecular assays and support for advancing tests toward market deployment.
Assay development and partnership collaborations
Collaborative development of infectious disease molecular assays and support for advancing tests toward market deployment.
Expertise Areas
- Point-of-care molecular diagnostics
- Infectious disease assay development
- Isothermal amplification chemistry
- Machine learning for assay design
Key Technologies
- Isothermal nucleic acid amplification
- Machine learning–driven assay design
- Point-of-care molecular diagnostics platform
- Compact multi-sample processing